Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants

Tülay Güran Başak Tezel Fatih Gurbuz Beray Selver Eklioğlu Nihal Hatipoglu Cengiz Kara Enver Şimşek Filiz Mine Çizmecioğlu-Jones Zeynep Alev Ozon Firdevs Baş Hasan Murat Aydın Feyza Darendelıler

Published in: Journal of clinical research in pediatric endocrinology (2018)

The incidence of CAH due to classical 21-OHD is higher in Turkey compared to previous reports. We, therefore, suggest that CAH be added to the newborn screening panel in Turkey. The use of steroid profiling as a second-tier test was found to improve the efficacy of the screening and reduce the number of false-positives.

Keyphrases

risk factors
emergency department